Jesper Roested
Vice President of Business Development
Diabetes
MC2 Biotek ApS
Denmark
Biography
Jesper Roested serves as Vice President of Business Development at MC2 Biotek. Mr. Roested serves as an Investment Director of VF Venture at Vækstfonden. He is responsible for business development of investment portfolio within the medical technology area. Prior to MC2 Biotek, he served as the Chief Executive Officer of 3D Danish Diagnostic Development A/S) for 3 years and lead the it through a strategic divestment. Mr. Roested commenced his career as a Management Consultant at McKinsey & Co, where he also completed a McKinsey & Co mini-MBA. Beyond management consulting, he has worked in the medical device industry and the pharmaceuticals industry for 14 years, including 7 years at Novo Nordisk A/S in positions involving business development, product marketing and product development. He serves as chairman at Microlytic ApS. He serves as a Director at Medotech A/S. Mr. Roested earned M.Sc. in Medical Elektronics and physics, medico engineer and supplementary Mini-M.B.A. through McKinsey & Co.
Research Interest
Business development, product marketing and product development
